Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis

This publication has 23 references indexed in Scilit:

• Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
  European Journal of Cancer Supplements, 2007
• Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*
  Oncology Research and Treatment, 2007
• Pharmacology of Systemic Antifungal Agents
  Clinical Infectious Diseases, 2006
• Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
  New England Journal of Medicine, 2004
• 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
  Clinical Infectious Diseases, 2002
• Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
  New England Journal of Medicine, 2002
• A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
  Clinical Infectious Diseases, 2000
• A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
  The American Journal of Medicine, 2000
• Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
  New England Journal of Medicine, 1999
• Emerging Fungal Pathogens in Immunocompromised Patients: Classification, Diagnosis, and Management
  Clinical Infectious Diseases, 1993